)
OrthoPediatrics (KIDS) investor relations material
OrthoPediatrics Jefferies London Healthcare Conference 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Strategic focus and market overview
Solely dedicated to pediatric orthopedics, serving a $6 billion global market with a focus on trauma, deformity, scoliosis, specialty bracing, and enabling technology.
Over 80 systems in the portfolio, with a consistent cadence of new product launches and a strong commitment to clinical education, hosting 300+ training sessions annually.
U.S. market focus on 300-400 children's hospitals, avoiding adult hospitals entirely, and expanding internationally to over 75 countries.
Business expansion through R&D and multiple M&A acquisitions, including recent specialty bracing and enabling technology companies.
Specialty bracing and enabling technology are key new growth areas, with significant investments and acquisitions since 2022.
Product innovation and pipeline
Accelerated product introduction since 2017, now offering advanced systems for trauma, deformity, and scoliosis, including 3D-printed navigation and zero-radiation systems.
Recent launches include the VertiGlide system for severe early-onset scoliosis and the DF2 Brace for hip dysplasia, with upcoming launches like 3P Mini and eLLi mechanical growing rod in 2026-2027.
Specialty bracing division (OPSB) is growing over 20% annually, with expansion of clinics from 26 to nearly 40, including the first international clinic in Ireland.
Enabling technology such as Playbook enhances OR workflow, surgeon support, and procedure safety, with strong surgeon adoption.
Continued investment in R&D and new technologies, with a robust pipeline for trauma, deformity, and scoliosis products.
Financial performance and outlook
Historical revenue growth over 20% annually (except during COVID), with 2025 guidance at $233.5M-$234.5M revenue and $15M-$17M adjusted EBITDA.
Third quarter is seasonally strongest due to school schedules, with unique sales patterns compared to other OEMs.
Significant improvement in free cash flow, targeting break-even in 2026, down from $40M cash usage two years ago to about half in 2025.
Strategic shift in the last 18 months to prioritize EBITDA and cash flow over pure growth, supported by $60M cash on hand at Q3 2024.
Anticipates continued aggressive growth, improved profitability, and financial independence over the next 18 months.
Next OrthoPediatrics earnings date
Next OrthoPediatrics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage